Answers are grounded in this paper and cite their sources.
No AccessJournal of Urology1 Apr 1983A Trial of Adjuvant Chemotherapy for Stage T3 Bladder Tumors C.A.C. Clyne, J.D. Jenkins, C.J. Smart, J. Guthrie, and R.B. Buchanan C.A.C. ClyneC.A.C. Clyne More articles by this author , J.D. JenkinsJ.D. Jenkins More articles by this author , C.J. SmartC.J. Smart More articles by this author , J. GuthrieJ. Guthrie More articles by this author , and R.B. BuchananR.B. Buchanan More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)52334-4AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail A total of 12 patients with stage T3 bladder tumors entered a pilot study of adjuvant chemotherapy with doxorubicin and 5-fiuorouracil after initial transurethral resection and before radiotherapy. Morbidity was minimal and mortality did not seem to be improved compared to a control group. © 1983 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 129Issue 4April 1983Page: 736-737 Advertisement Copyright & Permissions© 1983 by The American Urological Association Education and Research, Inc.MetricsAuthor Information C.A.C. Clyne More articles by this author J.D. Jenkins More articles by this author C.J. Smart More articles by this author J. Guthrie More articles by this author R.B. Buchanan More articles by this author Expand All Advertisement PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Clyne et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: